483 Hangzhou Huadong Med. Group Kangrun Pharmaceutical Jan 2015

483 Hangzhou Huadong Med. Group Kangrun Pharmaceutical Jan 2015

Jeffrey Meng FDA$119.00 - Available Now

FDA investigators audited the Hangzhou Huadong Med. Group Kangrun Pharmaceutical - Xiaofeng Town, China facility and issued 7 inspectional observations (via FDA 483) on 22 Jan 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 7
  • Inspection end: 22 Jan 2015
  • Location: Xiaofeng Town, China
  • FEI: 3008465758
Add To Cart